Poor solubility and bioavailability are limiting factors for the clinical application of curcumin. This study seeks to develop\npoloxamer/chitosan thermosensitive gel containing curcumin-cyclodextrin inclusion complex with enhanced brain bioavailability\nand antidepressant effect. The optimized gel had shorter gelation time and produced sustained release in vitro characterized\nwith non-Fickian diffusion. Pharmacokinetics of gel were evaluated using male Sprague-Dawley rats receiving 240
Loading....